Novel Vaccine Delivery Devices Market is estimated to be worth USD 1.5 billion in 2030

RootsAnalysis is pleased to announce the publication of its recent study, titled, “NovelVaccine Delivery Devices Market, 2019-2030”

Thereport features an extensive study of the current landscape and the likelyfuture opportunities associated with novel vaccine delivery devices, over thenext 10-12 years. Amongst other elements, the report includes:

·       A detailed assessment of the overall novelvaccine delivery devices market landscape, featuring an elaborate list ofdevice developers engaged in the development of novel vaccine delivery devices.

·       A detailed competitiveness analysis of novelvaccine delivery devices, taking into consideration the supplier power and keyproduct specifications.

·       An analysis evaluating the effectiveness ofvarious vaccines delivery devices in order to compare their respectivestrengths and capabilities based on a variety of parameters.

·       A detailed list of marketed and pipelinevaccine candidates that are anticipated to be developed in combination withnovel vaccine delivery devices in the near future.

·       Elaborate profiles of prominent productdevelopers engaged in the novel vaccine delivery devices domain (shortlisted onthe basis of the number of pipeline products).

·       An analysis of the partnerships that havebeen established in this domain, in the recent past.

·       A discussion on important, industry-specifictrends, key market drivers and challenges, under a comprehensive SWOTframework.

Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)

Requestfor Customization: https://www.rootsanalysis.com/reports/280/request-customization.html

GlobalNovel Vaccine Delivery Devices (By Value) 

Typeof Device

·       Electroporation-based Needle Free InjectionSystems

·       Oral Delivery Systems

·       Nasal Delivery Systems

·       Jet Injectors

·       Microneedle Patches

·       Microinjectors

Routeof Administration

·       Oral

·       Intramuscular

·       Intranasal

·       Intradermal

·       Subcutaneous

Typeof Vaccines

·       Bivalent Oral Polio Vaccine

·       BCG Vaccine

·       DTP-HepB-Hib Vaccine

·       Pneumococcal Conjugate Vaccine

·       Influenza Vaccine

·       Measles Vaccine

·       Tetanus-Diphtheria Vaccine

·       Others

KeyGeographical Region

·       North America

·       Europe

·       Asia Pacific

·       Rest of the World

Keycompanies covered in the report

·       3M

·       Becton Dickinson

·       Consort Medical

·       D’Antonio Consultants International

·       Enesi Pharma

·       Ichor Medical

·       Iconovo

·       Inovio Pharmaceuticals

·       PharmaJet

·       Union Medico

DownloadPDF Sample:

https://www.rootsanalysis.com/reports/280/request-sample.html    

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415